Effect of phenylephrine and endothelium on vasomotion in rat aorta involves potassium uptake

J Physiol Sci. 2013 Mar;63(2):103-11. doi: 10.1007/s12576-012-0240-9. Epub 2012 Nov 20.

Abstract

Vasomotion is defined as the rhythmic contractions in blood vessels, consisting of two components: vasoconstriction and oscillations of the plasma membrane potential. To determine whether vasomotion is associated with changes in K(+) uptake, we measured the effect of phenylephrine (PE) and acetylcholine (ACh) on the K(+) uptake and vascular reactivity in rat aortic rings. We found that the incubation of aortic rings with 10(-7) M PE (210 ± 28 mg maximum amplitude), and 10(-6) M ACh (177 ± 6 mg maximum amplitude) produced the highest rhythmic contractions. Both 10(-7) M PE and 10(-6) M ACh significantly increased K(+) uptake in endothelium-intact aorta versus control (121 % PE, 117 % ACh). Removal of the endothelium blunted rhythmic contractions and decreased K(+) uptake in presence of vasoactive substances (88 % PE, 81 % ACh). The inhibition of nitric oxide synthase with 10(-4) M L-NNA significantly reduced the rhythmic contractions, and it was reversed in the presence of 10(-8) M sodium nitroprusside (SNP; a nitric oxide donor). Also, we found that 10(-4) M L-NNA significantly decreased the effect of 10(-7) M PE on K(+) uptake in aortic rings (104 % PE + L-NNA vs. control). The incubation of endothelium-denuded rings with 10(-8) M SNP significantly increased the K(+) uptake (116 % SNP vs. control), similar to those observed in the presence of 10(-6) M ACh. The inhibition of protein kinase G with KT-5823 blocked SNP-mediated increase in K(+) uptake. In conclusion, these data suggest that a certain range of K(+) uptake is necessary to induce the rhythmic contractions in response to vasoactive substances.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology
  • Animals
  • Aorta / drug effects*
  • Aorta / metabolism
  • Calcium / metabolism
  • Cyclic GMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic GMP-Dependent Protein Kinases / metabolism
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / metabolism
  • Enzyme Inhibitors / pharmacology
  • Female
  • Membrane Potentials
  • Nitric Oxide / metabolism
  • Nitric Oxide Donors / pharmacology
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / metabolism
  • Periodicity
  • Phenylephrine / pharmacology*
  • Potassium / metabolism
  • Potassium Channel Blockers / pharmacology
  • Potassium Channels / drug effects*
  • Potassium Channels / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Time Factors
  • Vasoconstrictor Agents / pharmacology*

Substances

  • Enzyme Inhibitors
  • Nitric Oxide Donors
  • Potassium Channel Blockers
  • Potassium Channels
  • Vasoconstrictor Agents
  • Phenylephrine
  • Nitric Oxide
  • Nitric Oxide Synthase
  • Cyclic GMP-Dependent Protein Kinases
  • Acetylcholine
  • Potassium
  • Calcium